Back

Weekly Journal Scan: The jury is still out on beta-blockers following acute myocardial infarction with preserved ejection fraction after the ABYSS trial

European Heart Journal

14 December 2024
Organised by: Logo
Read full article
ESC Journals

Contributors

Daniela Pedicino
Daniela Pedicino

Author

Massimo Volpe
Massimo Volpe

Author

Sapienza University of Rome Rome , Italy

You may be interested in
thumbnail
Congress Presentation
Highlights from ABYSS - Beta blocker interruption in post-myocardial infarction patients
1 September 2024
thumbnail
Congress Session
Advancing heart failure diagnosis and management: insights from hemodynamics, inflammation, and emerging therapies
19 May 2025
thumbnail
Congress Presentation
Tends in beta-blocker administration and in prevalence of indications for their usage in heart failure with preserved ejection fraction: an analysis of randomized clinical trials
27 August 2021
thumbnail
Congress Presentation
Heart rate and cardiovascular outcomes with and without beta-blocker in post-mi patients: a pre-specified analysis of the ABYSS trial.
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources